Draft:Emmanuel Hui
 | Review waiting, please be patient.
This may take 4 months or more, since drafts are reviewed in no specific order. There are 4,500 pending submissions waiting for review.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Reviewer tools
|
Emmanuel Andrew Hui is a Hong Kong based life sciences entrepreneur, venture investor, and accelerator executive. He is the Chief Executive Officer of Tiger Jade Pebble Accelerator; as well as a Partner of Saltagen Ventures. He previously co-founded Moogene (KSE: 322970), a gene therapy company that listed on the Korean Stock Exchange in 2020.
Early Life
[edit]Hui grew up in Hong Kong. He has been involved in the arts and cultural scene from a young age, and played the Artful Dodger in a Hong Kong production of Oliver![1] As a child, Hui was recognized as a gifted case study in The Oxford Handbook of Children's Musical Cultures[2]
In 2023, he served as Line producer for H1 Music on the Hong Kong Philharmonic Orchestra's Metaverse Symphony. [3]
Hui also has a work by Hong Kong ink artist Wesley Tongson (1957-2012), Untitled (1985), on loan to Asia Society Hong Kong Center. [4]
Career
[edit]Moogene (2016-2020)
[edit]In December 2016, while still a senior at Dartmouth, Hui co-founded Moogene, a gene and cell therapy company, alongside three professors form Dartmouth and Harvard universities. The company was incorporated in both the United States and South Korea.[5]
Moogene's research focused on gene editing and gene therapy applications, including treatments for colon cancer chemotherapy resistance and androgennic alopecia, using CRISPR/Cas9 technology and ultrasound-microbubble delivery systems.[5]
Moogene went public on the Korean Stock Exchange on June 24, 2020.[6]
Pentepebble and Tiger Jade Pebble Accelerator (2020-Present)
[edit]In October 2020, Hui launched Pentepebble (also referred to as "Pebble"), his own direct early-stage investments fund, with support from Sagamore Investments. Pentepebble subsequently merged with Tiger Jade Capital - the USD fund of Tigermed (HKEX: 3347), one of Asia's largest contract research organizations - to form the Tiger Jade Pebble Accelerator.[7]
As CEO of Tiger Jade Pebble Accelerator, Hui focuses on identifying commercially viable technologies originating from Hong Kong universities and supporting their development from early research to market-ready companies.[8][9]
Hui has described Hong Kong as an "untapped gold mine" for life sciences investment, citing the nascent but growing nature of the local biotech industry and the city's proximity to mainland China.[7] However, Hui is also critical of local Hong Kong researchers for not understanding how to develop their work alongside international standards to convince investor participation. [10]
For his work with Pebble, Hui was recognized by Forbs as one of the 30 Under 30 for Asia - Finance and Venture Capital. [11]
Saltagen Ventures (2020-Present)
[edit]Hui Serves as a Domain Partner at Saltagen Ventures, an early stage venture capital firm founded in 2017 and based in Hong Kong, focused on science and technology startups across North America and Asia.[12] In this role, he focuses on deep biotechnology startups scaling between the North American and Asian markets.[13]
Board Membership and Advisory Roles
[edit]Hui holds a number of corporate board and institutional advisory positions
- Investment Committee Member, CUHK Innovation
- Board Member, Hong Kong Hospital Authority Central Institutional Review Board
- Hong Kong Trade Development Council, Trade Delegates and Steering Committee Member
- Advisory Board Member, Hong Kong Life Sciences Society
References
[edit]- ^ "Budding actors take on Oliver". South China Morning Post. 2006-07-23. Retrieved 2026-05-29.
- ^ Campbell, Patricia Shehan, Wiggins, Trevor (2013). The Oxford Handbook of Children's Musical Cultures. Oxford University Press. pp. 402–418. ISBN 978-0-19-020641-3.
{{cite book}}: CS1 maint: multiple names: authors list (link) - ^ "HK Phil Presents the First-ever Metaverse Symphony Performed both in a Concert Hall and The Sandbox Chow Sang Sang Jewellery Proudly Sponsors: Metaverse Symphony (5 & 6 May 2023) | HK Phil". www.hkphil.org. Retrieved 2026-05-29.
- ^ "Indoor Artworks | Asia Society". asiasociety.org. 2022-10-13. Retrieved 2026-05-29.
- ^ a b "Healthtech fund focuses on GBA | HKMB". Hong Kong Means Business. Retrieved 2026-05-29.
- ^ "Moogene Medi Co Ltd (322970:KS)". Bloomberg. 2020-06-24.
- ^ a b "【Retaining Excellence: The Principles of Cultivating Life Science Talent】Investing in Trial and Error". HKLSS. Retrieved 2026-05-15.
- ^ "Healthtech fund focuses on GBA | HKMB". Hong Kong Means Business. Retrieved 2026-05-15.
- ^ "Great Bay Bio Completes First Close of Series B Financing". www.hkstp.org. Retrieved 2026-05-29.
- ^ "5 years after first Covid case, why can't Hong Kong make home-grown vaccines?". South China Morning Post. 2025-01-26. Retrieved 2026-05-29.
- ^ "Emmanuel Hui". Forbes. Retrieved 2026-05-29.
- ^ "Team". www.saltagen.com. Retrieved 2026-05-15.
- ^ "Saltagen Ventures Portfolio Investments, Saltagen Ventures Funds, Saltagen Ventures Exits". www.cbinsights.com. Retrieved 2026-05-15.